Breaking News
October 19, 2018 - New urea sorbent could speed up the development of wearable artificial kidney
October 19, 2018 - Intensive care patients’ muscles less able to use fats for energy
October 19, 2018 - FDA Advisory Committee Recommends Approval of Dsuvia for the Treatment of Moderate-to-Severe Acute Pain
October 19, 2018 - 48,XXXY syndrome – Genetics Home Reference
October 19, 2018 - Physical exercise improves the elimination of toxic proteins from muscles
October 19, 2018 - How a new system improved wait times for Stanford kidney transplant patients
October 19, 2018 - Nutrition has bigger positive impact on bone mass and strength than exercise
October 19, 2018 - Study finds lack of progress in media representation of nurses over last 20 years
October 19, 2018 - Many people have trouble understanding differences between OCD and OCPD
October 19, 2018 - New family planning app found to be as effective as modern methods
October 19, 2018 - Gastric Banding, Metformin Similar for Improving Glycemia
October 19, 2018 - Physiologist publishes findings on the role of the protein titin in muscle contraction
October 19, 2018 - What digital health companies need to do to succeed
October 19, 2018 - N. Carolina Sees Alarming Spike in Heart Infections Among Opioid Users
October 19, 2018 - Video monitoring of TB therapy works well in urban and rural areas
October 19, 2018 - Determining acid-neutralizing capacity for OTC antacids
October 19, 2018 - Males who spend more time taking care of kids have greater reproductive success
October 18, 2018 - Study to explore bioethics of brain organoids
October 18, 2018 - Environmental conditions may drive development of multiple sclerosis
October 18, 2018 - Genetically modifying zebrafish provides more accurate disease models
October 18, 2018 - Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant
October 18, 2018 - 5 Strength-Training Mistakes to Avoid
October 18, 2018 - Immune system’s balancing act keeps bowel disease in check
October 18, 2018 - Anti-inflammatory drug effective for treating lymphedema symptoms | News Center
October 18, 2018 - Keeping Your Voice Young
October 18, 2018 - One-time universal screening recommended to tackle increase in hepatitis C
October 18, 2018 - Researchers to develop new stem cell-based strategies for treating vision disorders
October 18, 2018 - Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease
October 18, 2018 - Understanding AFib: Slowing down the dancing heart
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
October 18, 2018 - Cell death protein also damps inflammation
October 18, 2018 - AI pathology diagnostic tool developed using deep learning technology from Olympus
October 18, 2018 - Health Highlights: Oct. 15, 2018
October 18, 2018 - Largest study of ‘post-treatment controllers’ reveals clues about HIV remission
October 18, 2018 - Bad Blood in Silicon Valley: A conversation with John Carreyrou
October 18, 2018 - ANTRUK’s Annual Lecture sends out message on shortage of funds for antibiotic research
October 18, 2018 - NAM special publication outlines steps to ensure interoperability of health care systems
October 18, 2018 - Novel method uses just a drop of blood to monitor effect of lung cancer therapy
October 18, 2018 - New blood test could spare cancer patients from unnecessary chemotherapy
October 18, 2018 - Training young researchers to work with data volumes arising in the health sector
October 18, 2018 - New Metrohm IC method is reliable and convenient to use for zinc oxide assay
October 18, 2018 - Global AIDS, TB fight needs more money: health fund
October 18, 2018 - Understanding the forces that cause sports concussions
October 18, 2018 - Research points to new target for treating periodontitis
October 18, 2018 - New tool improves assessment of postpartum depression symptoms
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Report predicts life expectancy in 2040, Spain comes out on top
October 18, 2018 - Self-lubricating condoms may help raise condom usage
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy
October 18, 2018 - Autonomic nervous system directly controls stem cell proliferation, study shows
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - UC researcher focuses on light-mediated therapies to target breast cancer
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Mice study shows antibiotics are not always necessary to cure sepsis
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
Gene Therapy May Be Cure for Some With Rare Blood Disorder

Gene Therapy May Be Cure for Some With Rare Blood Disorder

image_pdfDownload PDFimage_print

WEDNESDAY, April 18, 2018 — Wanda Sihanath didn’t like the fact that her inherited blood disorder would not allow her to travel far from Chicago to attend college, but what could she do?

Without regular transfusions and blood testing, the beta-thalassemia she inherited from her parents could eventually cause her to become dangerously anemic.

“I wasn’t happy that I was adapting my college plans to my health care,” said Sihanath. She wanted to be free to go where she pleased, unshackled by her disorder.

Thanks to a revolutionary new genetic therapy, Sihanath hasn’t needed a blood transfusion for four years. She’s now 22 and a senior at Arizona State University studying biomedical engineering.

She is one of 15 out of 22 patients who became independent of transfusions after receiving the therapy, which replaced a defective gene in the stem cells of her bone marrow. Early results of the clinical trial are published in the April 19 issue of the New England Journal of Medicine.

“They have not required blood products of any kind for over a year, and for some it’s over three years,” said lead researcher Dr. Alexis Thompson, head of hematology and chair of childhood cancer and blood disorders at the Ann and Robert H. Lurie Children’s Hospital of Chicago.

Thalassemia is a group of inherited blood disorders that affect the production of hemoglobin, the protein in red blood cells that transports oxygen throughout the body.

Hemoglobin is made of two proteins, alpha globin and beta globin. In beta-thalassemia, genetic defects affect the production of the beta globin protein, reducing levels of hemoglobin in the blood.

There are an estimated 288,000 cases of beta-thalassemia across the world, making it one of the most common genetic diseases, according to an editorial accompanying the study. In the United States and the European Union, an estimated 15,000 people have the disorder and approximately 1,500 infants are born each year with it.

Patients with beta-thalassemia typically must begin receiving regular blood transfusions as an infant, so they don’t become anemic, Thompson said. Most will remain dependent on blood transfusions for the rest of their life.

Beta-thalassemia can be cured through a bone marrow transplant from a brother or sister, but that’s not an option for most, Thompson said.

“Unfortunately, the majority of individuals with thalassemia will not have a suitable matched sibling,” Thompson said. “Because of the lack of availability of appropriate donors, there has been a need for alternative treatments for thalassemia.”

In the experimental gene therapy, a person becomes his or her own donor of bone marrow stem cells. Medicines prompt the stem cells that create blood to temporarily circulate in the patient’s bloodstream, from which doctors gather and refine the cells, Thompson said.

Those stem cells are then exposed to a virus carrying the normal version of the beta globin gene, Thompson said. The cells adopt the normal gene, allowing them to produce healthy amounts of hemoglobin.

In the meantime, patients receive chemotherapy to kill off the defective bone marrow cells in their bodies. Once that’s done, the new cells are introduced via an IV drip into their veins, Thompson said.

“Because these are stem cells, they know where they really belong is the bone marrow,” Thompson said. “Even putting them into a vein, the cells know to travel to the bone marrow. Once they’re in the marrow, they settle in and begin dividing.”

Two-thirds of the patients who underwent this one-time treatment wound up with healthy levels of hemoglobin and have not needed transfusions, Thompson said.

“Of the ones that did not become independent, there was an almost 70 percent reduction in the volume and frequency of transfusion,” Thompson said. “There was clinical benefit in essentially all participants, with the majority of participants becoming transfusion-independent.”

Even better, the procedure did not cause any side effects.

There had been some concern that the virus would not act as anticipated, and might turn on cancer genes to trigger the development of leukemia in patients, explained Dr. Christopher Walsh, an associate professor of hematology and medical oncology at the Icahn School of Medicine at Mount Sinai in New York City.

“They don’t see that in this study, and the patients were studied for many years here, so that’s a good thing,” said Walsh, who wasn’t involved with the research.

Researchers will continue to track the patients for 15 years, to make sure no long-term health problems crop up, Thompson said.

The team continues to tweak the protocol to improve the ability of the virus to transfer the normal gene into patients’ stem cells, Thompson said. A larger phase 3 clinical trial is already underway.

Researchers also have been granted federal approval to test the procedure in children younger than 12, Thompson added.

“It’s been very gratifying to see patients who have really been able to thrive and to make plans and envision being able to accomplish so much, no longer dependent on transfusions,” Thompson said.

Sihanath agreed, saying she appreciates that she might one day decide to study abroad without worrying about her health care.

“Just being able to not stress about that has been nice,” she said.

More information

The American Academy of Family Physicians has more about thalassemia.

© 2018 HealthDay. All rights reserved.

Posted: April 2018

Tagged with:

About author

Related Articles